Clinical and immunological features of SLE
| Case | Disease | Age (y) | Prior course (years) | ACR criteria | Weight loss (kg) | Extradigestive features | ANA 1/ | Anti-dsDNA antibody | Anti-ENA antibody | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R | C | N | U | ||||||||||||||||
| 1 | SLE-like | 19 | 0 | 3 | 10 | − | − | − | + | 320 | − | anti-RNP | |||||||
| 2 | SLE | 28 | 7 | 5 | 5 | + | + | + | + | 4000 | 1000 | anti-Sm | |||||||
| 3 | SLE | 29 | 0 | 3 | 25 | + | − | − | − | 100 | − | anti-RNP | |||||||
| 4 | SLE | 34 | 1 | 6 | 40 | + | − | + | + | 400 | − | − | |||||||
| 5 | SLE | 29 | 1 | 5 | 12 | + | + | − | + | 5000 | 80 | anti-RNP | |||||||
ACR, American College of Rheumatology; R, rheumatological; C, cardiological; N, neurological; U, urological (reduced bladder capacity and bilateral ureteral distension); SLE, systemic lupus erythematosus.